Article
Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril.
European journal of clinical pharmacology - 1 Aug 2015
Oliveira-Paula G H, Lacchini R, Fontana V, Silva P S, Biagi C, Tanus-Santos Jose E
Abstract excerpt
PURPOSE: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor that affects blood pressure by promoting vasodilation mediated by nitric oxide. Angiotensin-converting enzyme inhibitors (ACEi) up-regulate the VEGF expression; thus, genetic polymorphisms in the VEGFA gene could affect the antihypertensive responses to these drugs. METHODS: Hypertensive patients (n = 102) were prospectively treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
